Home
The Company
GRG Gene Technology is a biotech company, located in southern of Switzerland (Canton Ticino), that was founded in early 2014 by a team of researchers in the field of plant genetics, biotechnologies and business consulting applied to economics activities characterized by strong innovation and expertise.
Mission
Our mission is focused on the development of innovative and effective therapeutic strategies for the cardiovascular diseases, using plant biotechnologies applied on the human health. Our innovative production and delivery system of anti-atherogenic APOA-1 muteins pave the way for a new avenue of therapeutic products in atherosclerosis and possibly other diseases, by virtue of a safe and cost-effective route of administration which is able to deliver optimal dosages of active principle.
Know-how
We have built our knowledge with determination, dedication and professionality, accepting the challenges and facing every setback with enthusiasm. GRG Gene Technology has expertise ranging from genetic engineering of cultivable plants to testing innovative therapeutic products in preclinical models of diseases.
